IFNG and neoplasm: If IFN-γ can inhibit EGFR/Erk1/2 and Wnt/β-catenin signaling pathways, as was reported [27], lack of IFN-γ receptor would be expected to lead to an upregulation of those pathways in tumor cells, consequently driving the proliferation of tumor cells.